$1.10
-0.05[-4.35%]
At close: May 7
$1.10
0[0.00%]
After Hours: 4:00PM EDT
Karyopharm Therapeutics
(NASDAQ:KPTI)Karyopharm Therapeutics Stock (NASDAQ:KPTI), Earnings Estimates, EPS, and Revenue
Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.330
Quarterly Revenue Estimate
$34.5M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$146M
Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?
Karyopharm Therapeutics (KPTI) is scheduled to report earnings on July 31, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?
The Actual EPS was $-0.36, which missed the estimate of $-0.31.
What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?
The Actual Revenue was $33.7M, which missed the estimate of $35.4M.
Browse earnings estimates, EPS, and revenue on all stocks.